Season 5, Episode 1 - EASL CPGs on Vascular Liver Diseases: What’s New?

This episode addresses key challenges in vascular complications of liver disease, including the management of portal vein thrombosis (PVT) in patients with and without cirrhosis. Experts will explore controversies surrounding long-term anticoagulation therapy and discuss insights from the CIRROXABAN paper. Additionally, the episode will shed light on the management of splanchnic artery aneurysms, offering valuable guidance for clinical practice.

Faculty: Pierre-Emmanuel Rautou (Moderator), Sarwa Darwish Murad (Faculty), Juan-Carlos Garcia-Pagan (Faculty), Valérie Vilgrain (Faculty)

Related episodes:

• S4E11 – YI Choice: Gene therapy for liver disease — RNA interference and beyond
• S4E6 – Regenerating the liver graft with a machine?
• S3E11 – Regenerative Hepatology: From stem cells to tissue engineering
• S2E9 – YI Choice: Propelling liver cell biology into the third dimension